Bone Tissue engineering: Current strategies and techniques-Part I: Scaffolds

Tissue Engineering - Part B: Reviews

Volumn 18, Issue 4, 2012, Pages 246-257

  Szpalski, Caroline ^a   Wetterau, Meredith ^a   Barr, Jason ^a   Warren, Stephen M ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL PROCESS; BONE ENGINEERING; BONE REPAIR; BONE TISSUE ENGINEERING; CELL TYPES; CELLULAR ACTIVATION; CHONDROCYTES; DYNAMIC PROCESS; IN-VIVO; MESENCHYMAL STEM CELL; MICROENVIRONMENTS; OSTEOCYTES; SEQUENCE OF EVENTS; VASCULOGENIC;

BONE; CELL CULTURE; OSTEOBLASTS;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; TISSUE SCAFFOLD;

BONE MATRIX; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CARTILAGE CELL; CELL ACTIVATION; CELL TYPE; HUMAN; MATERIALS TESTING; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CALCIUM SULFATE; DEVICE APPROVAL; HUMANS; MODELS, BIOLOGICAL; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84864267743     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2011.0427     Document Type: Review

References (153)

1. Allori, A.C., Sailon, A.M., and Warren, S.M. Biological basis of bone formation, remodeling, and repair-part I: biochemical signaling molecules. Tissue Eng Part B Rev 14, 259, 2008.
2. Choi, K.H., Choi, B.H., Park, S.R., Kim, B.J., and Min, BH. The chondrogenic differentiation of mesenchymal stem cells on an extracellular matrix scaffold derived from porcine chondrocytes. Biomaterials 31, 5355, 2010.
3. Narayanan, K., Leck, K.J., Gao, S., and Wan, A.C. Threedimensional reconstituted extracellular matrix scaffolds for tissue engineering. Biomaterials 30, 4309, 2009.
4. Costa-Pinto, A.R., Salgado, A.J., Correlo, V.M., Sol, P., Bhattacharya, M., Charbord, P., et al. Adhesion, proliferation, and osteogenic differentiation of a mouse mesenchymal stem cell line (BMC9) seeded on novel melt-based chitosan/polyester 3D porous scaffolds. Tissue Eng Part A 14, 1049, 2008.
5. Fong, K.D., Warren, S.M., Loboa, E.G., Henderson, J.H., Fang, T.D., Cowan, C.M., et al. Mechanical strain affects dura mater biological processes: implications for immature calvarial healing. Plast Reconstr Surg 112, 1312, 2003.
6. Nandi, S.K., Roy, S., Mukherjee, P., Kundu, B., De, D.K., and Basu, D. Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res 132, 15, 2010.
7. Holzmann, P., Niculescu-Morzsa, E., Zwickl, H., Halbwirth, F., Pichler, M., Matzner, M., et al. Investigation of bone allografts representing different steps of the bone bank procedure using the CAM-model. ALTEX 27, 97, 2010.
8. Johnson, A.J., and Herschler, B.A. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater 1, 16, 2010.
9. Sohn, D.S., Bae, M.S., Choi, B.J., An, K.M., and Shin, H.I. Efficacy of demineralized bone matrix paste for maxillary sinus augmentation: a histologic and clinical study in humans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108, 30, 2009.
10. Woolfson, D.N., and Mahmoud, Z.N. More than just bare scaffolds: towards multi-component and decorated fibrous biomaterials. Chem Soc Rev 39, 3464, 2010.
11. Arrington, ED., Smith, W.J., Chambers, H.G., Bucknell, A.L., and Davino, N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 300, 1996.
12. Tour, G., Wendel, M., and Tcacencu, I. Cell-derived matrix enhances osteogenic properties of hydroxyapatite. Tissue Eng Part A 17, 127, 2010.
13. Albrektsson, T., and Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 10 Suppl 2, 96, 2001.
14. Petite, H., Viateau, V., Bensaid, W., Meunier, A., de Pollak, C., Bourguignon, M., et al. Tissue-engineered bone regeneration. Nat Biotechnol 18, 959, 2000.
15. Cushnie, E.K., Khan, Y.M., and Laurencin, C.T. Tissueengineered matrices as functional delivery systems: adsorption and release of bioactive proteins from degradable composite scaffolds. J Biomed Mater Res A 94, 568, 2010.
16. Sahoo, S., Ang, L.T., Goh, J.C., and Toh, S.L. Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. J Biomed Mater Res A 93, 1539, 2010.
17. Sahoo, S., Toh, S.L., and Goh, J.C. A bFGF-releasing silk/ PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells. Biomaterials 31, 2990, 2010.
18. Trubiani, O., Fulle, S., Traini, T., Paludi, M., la Rovere, R., Orciani, M., et al. Functional assay, expression of growth factors and proteins modulating bone-arrangement in human osteoblasts seeded on an anorganic bovine bone biomaterial. Eur Cell Mater 20, 72, 2010.
19. Yanoso-Scholl, L., Jacobson, J.A., Bradica, G., Lerner, A.L., O'Keefe, R.J., Schwarz, E.M., et al. Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds for bone tissue engineering. J Biomed Mater Res A 95, 717, 2010.
20. Zippel, N., Schulze, M., and Tobiasch, E. Biomaterials and mesenchymal stem cells for regenerative medicine. Recent Pat Biotechnol 4, 1, 2010.
21. Moore, W.R., Graves, S.E., and Bain, G.I. Synthetic bone graft substitutes. ANZ J Surg 71, 354, 2001.
22. Barrere, F., van Blitterswijk, C.A., and de Groot, K. Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomedicine 1, 317, 2006.
23. Tay, B.K., Patel, V.V., and Bradford, D.S. Calcium sulfateand calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop Clin North Am 30, 615, 1999.
24. Larsson, S. Calcium phosphates: what is the evidence? J Orthop Trauma 24 Suppl 1, S41, 2010.
25. Osborn, J.F., and Newesely, H. The material science of calcium phosphate ceramics. Biomaterials 1, 108, 1980.
26. Albee, F.H. Studies in bone growth: triple calcium phosphate as a stimulus to osteogenesis. Ann Surg 71, 32, 1920.
27. Lu, Z., and Zreiqat, H. Beta-tricalcium phosphate exerts osteoconductivity through alpha2beta1 integrin and downstream MAPK/ERK signaling pathway. Biochem Biophys Res Commun 394, 323, 2010.
28. Jarcho, M., Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res 259, 1981.
29. Hing, K.A., Wilson, L.F., and Buckland, T. Comparative performance of three ceramic bone graft substitutes. Spine J 7, 475, 2007.
30. Umeda, H., Kanemaru, S., Yamashita, M., Kishimoto, M., Tamura, Y., Nakamura, T., et al. Bone regeneration of canine skull using bone marrow-derived stromal cells and beta-tricalcium phosphate. Laryngoscope 117, 997, 2007.
31. Nienhuijs, M.E., Walboomers, X.F., Briest, A., Merkx, M.A., Stoelinga, P.J., and Jansen, J.A. Healing of bone defects in the goat mandible, using COLLOSS E and betatricalciumphosphate. J Biomed Mater Res B Appl Biomater 92, 517, 2010.
32. Nolff, M.C., Gellrich, N.C., Hauschild, G., Fehr, M., Bormann, K.H., Rohn, K., et al. Comparison of two betatricalcium phosphate composite grafts used for reconstruction of mandibular critical size bone defects. Vet Comp Orthop Traumatol 22, 96, 2009.
33. Zhao, J., Hu, J., Wang, S., Sun, X., Xia, L., Zhang, X., et al. Combination of beta-TCP and BMP-2 gene-modified bMSCs to heal critical size mandibular defects in rats. Oral Dis 16, 46, 2010.
34. Walsh, W.R., Vizesi, F., Michael, D., Auld, J., Langdown, A., Oliver, R., et al. Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials 29, 266, 2008.
35. van der Pol, U., Mathieu, L., Zeiter, S., Bourban, P.E., Zambelli, P.Y., Pearce, S.G., et al. Augmentation of bone defect healing using a new biocomposite scaffold: an in vivo study in sheep. Acta Biomater 6, 3755, 2010.
36. Jacobson, J.A., Yanoso Scholl, L., Reynolds, D.G., Dadali, T., Bradica, G., Bukata, S., et al. Teriparatide therapy and beta-TCP enhance scaffold reconstruction of mouse femoral defects. Tissue Eng Part A 17, 389, 2010.
37. Liu, Y., Pei, G., and Jiang, S. [New porous beta-tricalcium phosphate as scaffold for bone tissue engineering]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21, 1123, 2007.
38. Yang, P., Wang, C., Shi, Z., Huang, X., Dang, X., Li, X., et al. rhVEGF 165 delivered in a porous beta-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii. J Biomed Mater Res A 92, 626, 2010.
39. Abarrategi, A., Moreno-Vicente, C., Ramos, V., Aranaz, I., Sanz Casado, J.V., and Lopez-Lacomba, J.L. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application. Tissue Eng Part A 14, 1305, 2008.
40. Sohier, J., Daculsi, G., Sourice, S., de Groot, K., and Layrolle, P. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J Biomed Mater Res A 92, 1105, 2010.
41. Uchida, M., Agata, H., Sagara, H., Shinohara, Y., Kagami, H., and Asahina, I. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2. J Biomed Mater Res A 91, 84, 2009.
42. E, L.L., Xu, L.L., Wu, X., Wang, D.S., Lv, Y., Wang, J.Z., et al. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein- 2, and beta-tricalcium phosphate play an important role in bone tissue engineering. Tissue Eng Part A 16, 2927, 2010.
43. Jiang, X.Q., Sun, X.J., Lai, H.C., Zhao, J., Wang, S.Y., and Zhang, Z.Y. Maxillary sinus floor elevation using a tissueengineered bone complex with beta-TCP and BMP-2 genemodified bMSCs in rabbits. Clin Oral Implants Res 20, 1333, 2009.
44. Ozawa, T., Yoshihara, K., Koyama, N., Watanabe, Y., Shiono, N., and Takanashi, Y. Clinical efficacy of heparinbonded bypass circuits related to cytokine responses in children. Ann Thorac Surg 69, 584, 2000.
45. Liu, Q., Cen, L., Yin, S., Chen, L., Liu, G., Chang, J., et al. A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and beta-TCP ceramics. Biomaterials 29, 4792, 2008.
46. McCullen, S.D., Miller, P.R., Gittard, S.D., Gorga, R.E., Pourdeyhimi, B., Narayan, R.J., et al. In situ collagen polymerization of layered cell-seeded electrospun scaffolds for bone tissue engineering applications. Tissue Eng Part C Methods 16, 1095, 2010.
47. Hao, W., Pang, L., Jiang, M., Lv, R., Xiong, Z., and Hu, Y.Y. Skeletal repair in rabbits using a novel biomimetic composite based on adipose-derived stem cells encapsulated in collagen I gel with PLGA-beta-TCP scaffold. J Orthop Res 28, 252, 2010.
48. Okuda, T., Uysal, A.C., Tobita, M., Hyakusoku, H., and Mizuno, H. Prefabrication of tissue engineered bone grafts: an experimental study. Ann Plast Surg 64, 98, 2010.
49. Kuhbier, J.W., Weyand, B., Sorg, H., Radtke, C., Vogt, P.M., and Reimers, K. [Stem cells from fatty tissue: a new resource for regenerative medicine?]. Chirurg 81, 826, 2010.
50. Murshed, M., Harmey, D., Millan, J.L., McKee, M.D., and Karsenty, G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19, 1093, 2005.
51. Hollinger, J.O., and Battistone, G.C. Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin Orthop Relat Res 290, 1986.
52. Yoshikawa, H., and Myoui, A. Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 8, 131, 2005.
53. Patel, M., Dunn, T.A., Tostanoski, S., and Fisher, J.P. Cyclic acetal hydroxyapatite composites and endogenous osteogenic gene expression of rat marrow stromal cells. J Tissue Eng Regen Med 4, 422, 2010.
54. Misch, C.E., and Dietsh, F. Bone-grafting materials in implant dentistry. Implant Dent 2, 158, 1993.
55. Holmes, R.E., Wardrop, R.W., and Wolford, L.M. Hydroxylapatite as a bone graft substitute in orthognathic surgery: histologic and histometric findings. J Oral Maxillofac Surg 46, 661, 1988.
56. Hulbert, S.F., Morrison, S.J., and Klawitter, J.J. Tissue reaction to three ceramics of porous and non-porous structures. J Biomed Mater Res 6, 347, 1972.
57. Wang, X., and Ni, Q. Determination of cortical bone porosity and pore size distribution using a low field pulsed NMR approach. J Orthop Res 21, 312, 2003.
58. Holmes, R.E., and Hagler, H.K. Porous hydroxyapatite as a bone graft substitute in cranial reconstruction: a histometric study. Plast Reconstr Surg 81, 662, 1988.
59. Dutta Roy, T., Simon, J.L., Ricci, J.L., Rekow, E.D., Thompson, V.P., and Parsons, J.R. Performance of hydroxyapatite bone repair scaffolds created via three-dimensional fabrication techniques. J Biomed Mater Res A 67, 1228, 2003.
60. Kim, H.W., Shin, S.Y., Kim, H.E., Lee, Y.M., Chung, C.P., Lee, H.H., et al. Bone formation on the apatite-coated zirconia porous scaffolds within a rabbit calvarial defect. J Biomater Appl 22, 485, 2008.
61. Lew, D., Farrell, B., Bardach, J., and Keller, J. Repair of craniofacial defects with hydroxyapatite cement. J Oral Maxillofac Surg 55, 1441; discussion 9-51. 1997.
62. Bakker, A.D., Schrooten, J., van Cleynenbreugel, T., Vanlauwe, J., Luyten, J., Schepers, E., et al. Quantitative screening of engineered implants in a long bone defect model in rabbits. Tissue Eng Part C Methods 14, 251, 2008.
63. Kasten, P., Vogel, J., Geiger, F., Niemeyer, P., Luginbuhl, R., and Szalay, K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29, 3983, 2008.
64. Nair, M.B., Varma, H.K., Menon, K.V., Shenoy, S.J., and John, A. Tissue regeneration and repair of goat segmental femur defect with bioactive triphasic ceramic-coated hydroxyapatite scaffold. J Biomed Mater Res A 91, 855, 2009.
65. Yuan, J., Zhu, L., Wang, M., Cui, L., Liu, W., and Cao, Y.L. [Repair of canine segmental mandibular defects using autogenous bone marrow stromal cells and coralline hydroxyapatite]. Zhonghua Kou Qiang Yi Xue Za Zhi 41, 94, 2006.
66. Niemeyer, P., Szalay, K., Luginbuhl, R., Sudkamp, N.P., and Kasten, P. Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. Acta Biomater 6, 900, 2010.
67. Li, J., Li, Y., Ma, S., Gao, Y., Zuo, Y., and Hu, J. Enhancement of bone formation by BMP-7 transduced MSCs on biomimetic nano-hydroxyapatite/polyamide composite scaffolds in repair of mandibular defects. J Biomed Mater Res A 95, 973, 2010.
68. Jones, G.L., Walton, R., Czernuszka, J., Griffiths, S.L., El Haj, A.J., and Cartmell, S.H. Primary human osteoblast culture on 3D porous collagen-hydroxyapatite scaffolds. J Biomed Mater Res A 94, 1244, 2010.
69. Nitzsche, H., Lochmann, A., Metz, H., Hauser, A., Syrowatka, F., Hempel, E., et al. Fabrication and characterization of a biomimetic composite scaffold for bone defect repair. J Biomed Mater Res A 94, 298, 2010.
70. Xue, D., Zheng, Q., Zong, C., Li, Q., Li, H., Qian, S., et al. Osteochondral repair using porous poly(lactide-co-glycolide)/ nano-hydroxyapatite hybrid scaffolds with undifferentiated mesenchymal stem cells in a rat model. J Biomed Mater Res A 94, 259, 2010.
71. Verma, D., Katti, K.S., and Katti, D.R. Osteoblast adhesion, proliferation and growth on polyelectrolyte complex-hydroxyapatite nanocomposites. Philos Transact A Math Phys Eng Sci 368, 2083, 2010.
72. Fleming, J.E., Jr., Cornell, C.N., and Muschler, G.F. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am 31, 357, 2000.
73. Azami, M., Samadikuchaksaraei, A., and Poursamar, S.A. Synthesis and characterization of a laminated hydroxyapatite/ gelatin nanocomposite scaffold with controlled pore structure for bone tissue engineering. Int J Artif Organs 33, 86, 2010.
74. Buckley, C.T., and O'Kelly, K.U. Fabrication and characterization of a porous multidomain hydroxyapatite scaffold for bone tissue engineering investigations. J Biomed Mater Res B Appl Biomater 93, 459, 2010.
75. Guarino, R.D., Dike, L.E., Haq, T.A., Rowley, J.A., Pitner, J.B., and Timmins, M.R. Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration. Biotechnol Bioeng 86, 775, 2004.
76. Guo, D., Xu, K., and Han, Y. The in situ synthesis of biphasic calcium phosphate scaffolds with controllable compositions, structures, and adjustable properties. J Biomed Mater Res A 88, 43, 2009.
77. LeGeros, R.Z., Lin, S., Rohanizadeh, R., Mijares, D., and LeGeros, J.P. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med 14, 201, 2003.
78. Piattelli, A., Scarano, A., and Mangano, C. Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials 17, 1767, 1996.
79. Sendemir-Urkmez, A., and Jamison, R.D. The addition of biphasic calcium phosphate to porous chitosan scaffolds enhances bone tissue development in vitro. J Biomed Mater Res A 81, 624, 2007.
80. Ramay, H.R., and Zhang, M. Biphasic calcium phosphate nanocomposite porous scaffolds for load-bearing bone tissue engineering. Biomaterials 25, 5171, 2004.
81. Schumacher, M., Deisinger, U., Detsch, R., and Ziegler, G. Indirect rapid prototyping of biphasic calcium phosphate scaffolds as bone substitutes: influence of phase composition, macroporosity and pore geometry on mechanical properties. J Mater Sci Mater Med 21, 3119, 2010.
82. Polak, S.J., Levengood, S.K., Wheeler, M.B., Maki, A.J., Clark, S.G., and Johnson, A.J. Analysis of the roles of microporosity and BMP-2 on multiple measures of bone regeneration and healing in calcium phosphate scaffolds. Acta Biomater 7, 1760, 2011.
83. Shi, H., Ma, J., Zhao, N., Chen, Y., and Liao, Y. Periodontal regeneration in experimentally-induced alveolar bone dehiscence by an improved porous biphasic calcium phosphate ceramic in beagle dogs. J Mater Sci Mater Med 19, 3515, 2008.
84. Peng, J., Wen, C., Wang, A., Wang, Y., Xu, W., Zhao, B., et al. Micro-CT-based bone ceramic scaffolding and its performance after seeding with mesenchymal stem cells for repair of load-bearing bone defect in canine femoral head. J Biomed Mater Res B Appl Biomater 96, 316, 2011.
85. Kruyt, M.C., Dhert, W.J., Yuan, H., Wilson, C.E., van Blitterswijk, C.A., Verbout, A.J., et al. Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 22, 544, 2004.
86. Schopper, C., Ziya-Ghazvini, F., Goriwoda, W., Moser, D., Wanschitz, F., Spassova, E., et al. HA/TCP compounding of a porous CaP biomaterial improves bone formation and scaffold degradation-a long-term histological study. J Biomed Mater Res B Appl Biomater 74, 458, 2005.
87. Jafarian, M., Eslaminejad, M.B., Khojasteh, A., Mashhadi Abbas, F., Dehghan, M.M., Hassanizadeh, R., et al. Marrowderived mesenchymal stem cells-directed bone regeneration in the dog mandible: a comparison between biphasic calcium phosphate and natural bone mineral. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105, 14, 2008.
88. Wang, T., Tian, W.D., Liu, L., Cheng, X.Z., Liao, Y.M., and Li, S.W. [The study of cell biocompatibility of new pattern biphasic calcium phosphate nanocomposite in vitro]. Hua Xi Kou Qiang Yi Xue Za Zhi 23, 106, 2005.
89. Teixeira, C.C., Nemelivsky, Y., Karkia, C., and Legeros, R.Z. Biphasic calcium phosphate: a scaffold for growth plate chondrocyte maturation. Tissue Eng 12, 2283, 2006.
90. Brown, W.E., Eidelman, N., and Tomazic, B. Octacalcium phosphate as a precursor in biomineral formation. Adv Dent Res 1, 306, 1987.
91. Anada, T., Kumagai, T., Honda, Y., Masuda, T., Kamijo, R., Kamakura, S., et al. Dose-dependent osteogenic effect of octacalcium phosphate on mouse bone marrow stromal cells. Tissue Eng Part A 14, 965, 2008.
92. Liu, Y., Shelton, R., Gbureck, U., and Barralet, J. Influence of calcium phosphate crystal morphology on the adhesion, spreading, and growth of bone derived cells. J Biomed Mater Res A 90, 972, 2009.
93. Suzuki, O., Kamakura, S., Katagiri, T., Nakamura, M., Zhao, B., Honda, Y., et al. Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials 27, 2671, 2006.
94. Haberstroh, K., Ritter, K., Kuschnierz, J., Bormann, K.H., Kaps, C., Carvalho, C., et al. Bone repair by cell-seeded 3Dbioplotted composite scaffolds made of collagen treated tricalciumphosphate or tricalciumphosphate-chitosan- collagen hydrogel or PLGA in ovine critical-sized calvarial defects. J Biomed Mater Res B Appl Biomater 93, 520, 2010.
95. Kamakura, S., Sasaki, K., Homma, T., Honda, Y., Anada, T., Echigo, S., et al. The primacy of octacalcium phosphate collagen composites in bone regeneration. J Biomed Mater Res A 83, 725, 2007.
96. Fuji, T., Anada, T., Honda, Y., Shiwaku, Y., Koike, H., Kamakura, S., et al. Octacalcium phosphate-precipitated alginate scaffold for bone regeneration. Tissue Eng Part A 15, 3525, 2009.
97. Kamakura, S., Nakajo, S., Suzuki, O., and Sasano, Y. New scaffold for recombinant human bone morphogenetic protein- 2. J Biomed Mater Res A 71, 299, 2004.
98. Kamakura, S., Sasaki, K., Honda, Y., Anada, T., and Suzuki, O. Octacalcium phosphate combined with collagen orthotopically enhances bone regeneration. J Biomed Mater Res B Appl Biomater 79, 210, 2006.
99. Kawai, T., Anada, T., Honda, Y., Kamakura, S., Matsui, K., Matsui, A., et al. Synthetic octacalcium phosphate augments bone regeneration correlated with its content in collagen scaffold. Tissue Eng Part A 15, 23, 2009.
100. Kamakura, S., Sasaki, K., Honda, Y., Anada, T., Matsui, K., Echigo, S., et al. Dehydrothermal treatment of collagen influences on bone regeneration by octacalcium phosphate (OCP) collagen composites. J Tissue Eng Regen Med 1, 450, 2007.
101. Pietrzak, W.S., and Ronk, R. Calcium sulfate bone void filler: a review and a look ahead. J Craniofac Surg 11, 327, 2000.
102. Reynolds, M.A., Aichelmann-Reidy, M.E., Kassolis, J.D., Prasad, H.S., and Rohrer, M.D. Calcium sulfate-carboxymethylcellulose bone graft binder: Histologic and morphometric evaluation in a critical size defect. J Biomed Mater Res B Appl Biomater 83, 451, 2007.
103. Vaccaro, AR. The role of the osteoconductive scaffold in synthetic bone graft. Orthopedics 25, s571-8. 2002.
104. Coetzee, A.S. Regeneration of bone in the presence of calcium sulfate. Arch Otolaryngol 106, 405, 1980.
105. Sidqui, M., Collin, P., Vitte, C., and Forest, N. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials 16, 1327, 1995.
106. Peltier, L.F. The use of plaster of paris to fill large defects in bone. Am J Surg 97, 311, 1959.
107. Gao, C., Gao, J., You, X., Huo, S., Li, X., Zhang, Y., et al. Fabrication of calcium sulfate/PLLA composite for bone repair. J Biomed Mater Res A 73, 244, 2005.
108. Gao, C., Huo, S., Li, X., You, X., Zhang, Y., and Gao, J. Characteristics of calcium sulfate/gelatin composite biomaterials for bone repair. J Biomater Sci Polym Ed 18, 799, 2007.
109. Zhao, J., Lu, X., Duan, K., Guo, L.Y., Zhou, S.B., and Weng, J. Improving mechanical and biological properties of macroporous HA scaffolds through composite coatings. Colloids Surf B Biointerfaces 74, 159, 2009.
110. Nandakumar, A., Fernandes, H., de Boer, J., Moroni, L., Habibovic, P., and van Blitterswijk, C.A. Fabrication of bioactive composite scaffolds by electrospinning for bone regeneration. Macromol Biosci 10, 1365, 2010.
111. Venugopal, J., Prabhakaran, M.P., Zhang, Y., Low, S., Choon, A.T., and Ramakrishna, S. Biomimetic hydroxyapatite- containing composite nanofibrous substrates for bone tissue engineering. Philos Transact A Math Phys Eng Sci 368, 2065, 2010.
112. Nisbet, D.R., Forsythe, J.S., Shen, W., Finkelstein, D.I., and Horne, M.K. Review paper: a review of the cellular response on electrospun nanofibers for tissue engineering. J Biomater Appl 24, 7, 2009.
113. Park, K.E., Jung, S.Y., Lee, S.J., Min, B.M., and Park, W.H. Biomimetic nanofibrous scaffolds: preparation and characterization of chitin/silk fibroin blend nanofibers. Int J Biol Macromol 38, 165, 2006.
114. Yoshimoto, H., Shin, Y.M., Terai, H., and Vacanti, J.P. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 24, 2077, 2003.
115. Orimo, H., and Shimada, T. The role of tissue-nonspecific alkaline phosphatase in the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-2 human osteoblast-like cells. Mol Cell Biochem 315, 51, 2008.
116. Osathanon, T., Giachelli, C.M., and Somerman, M.J. Immobilization of alkaline phosphatase on microporous na- nofibrous fibrin scaffolds for bone tissue engineering. Biomaterials 30, 4513, 2009.
117. Mavis, B., Demirtas, T.T., Gumusderelioglu, M., Gunduz, G., and Colak, U. Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate. Acta Biomater 5, 3098, 2009.
118. Gupta, D., Venugopal, J., Mitra, S., Giri Dev, V.R., and Ramakrishna, S. Nanostructured biocomposite substrates by electrospinning and electrospraying for the mineralization of osteoblasts. Biomaterials 30, 2085, 2009.
119. McCullen, S.D., Zhu, Y., Bernacki, S.H., Narayan, R.J., Pourdeyhimi, B., Gorga, R.E., et al. Electrospun composite poly(L-lactic acid)/tricalcium phosphate scaffolds induce proliferation and osteogenic differentiation of human adipose- derived stem cells. Biomed Mater 4, 035002, 2009.
120. Erisken, C., Kalyon, D.M., and Wang, H. Functionally graded electrospun polycaprolactone and beta-tricalcium phosphate nanocomposites for tissue engineering applications. Biomaterials 29, 4065, 2008.
121. Venugopal, J., Low, S., Choon, A.T., and Ramakrishna, S. Interaction of cells and nanofiber scaffolds in tissue engineering. J Biomed Mater Res B Appl Biomater 84, 34, 2008.
122. Srouji, S., Kizhner, T., Suss-Tobi, E., Livne, E., and Zussman, E. 3-D Nanofibrous electrospun multilayered construct is an alternative ECM mimicking scaffold. J Mater Sci Mater Med 19, 1249, 2008.
123. Ma, K., Chan, C.K., Liao, S., Hwang, W.Y., Feng, Q., and Ramakrishna, S. Electrospun nanofiber scaffolds for rapid and rich capture of bone marrow-derived hematopoietic stem cells. Biomaterials 29, 2096, 2008.
124. Li, C., Vepari, C., Jin, H.J., Kim, H.J., and Kaplan, D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27, 3115, 2006.
125. Yoon, H., and Kim, G. A three-dimensional polycaprolactone scaffold combined with a drug delivery system consisting of electrospun nanofibers. J Pharm Sci 100, 424, 2011.
126. Andric, T., Wright, L.D., and Freeman, J.W. Rapid mineralization of electrospun scaffolds for bone tissue engineering. J Biomater Sci Polym Ed 22, 1535, 2010.
127. Chen, J., Chu, B., and Hsiao, B.S. Mineralization of hydroxyapatite in electrospun nanofibrous poly(L-lactic acid) scaffolds. J Biomed Mater Res A 79, 307, 2006.
128. Zhang, Y., Reddy, V.J., Wong, S.Y., Li, X., Su, B., Ramakrishna, S., et al. Enhanced biomineralization in osteoblasts on a novel electrospun biocomposite nanofibrous substrate of hydroxyapatite/collagen/chitosan. Tissue Eng Part A 16, 1949, 2010.
129. Madurantakam, P.A., Rodriguez, I.A., Cost, C.P., Viswanathan, R., Simpson, D.G., Beckman, M.J., et al. Multiple factor interactions in biomimetic mineralization of electrospun scaffolds. Biomaterials 30, 5456, 2009.
130. Kim, G.H. Electrospun PCL nanofibers with anisotropic mechanical properties as a biomedical scaffold. Biomed Mater 3, 025010, 2008.
131. Catledge, S.A., Clem, W.C., Shrikishen, N., Chowdhury, S., Stanishevsky, A.V., Koopman, M., et al. An electrospun triphasic nanofibrous scaffold for bone tissue engineering. Biomed Mater 2, 142, 2007.
132. Venugopal, J., Low, S., Choon, A.T., Sampath Kumar, T.S., and Ramakrishna, S. Mineralization of osteoblasts with electrospun collagen/hydroxyapatite nanofibers. J Mater Sci Mater Med 19, 2039, 2008.
133. Venugopal, J.R., Low, S., Choon, A.T., Kumar, A.B., and Ramakrishna, S. Nanobioengineered electrospun composite nanofibers and osteoblasts for bone regeneration. Artif Organs 32, 388, 2008.
134. Prabhakaran, M.P., Venugopal, J., and Ramakrishna, S. Electrospun nanostructured scaffolds for bone tissue engineering. Acta Biomater 5, 2884, 2009.
135. Liu, K.L., Choo, E.S., Wong, S.Y., Li, X., He, C.B., Wang. J., et al. Designing poly[(R)-3-hydroxybutyrate]-based polyurethane block copolymers for electrospun nanofiber scaffolds with improved mechanical properties and enhanced mineralization capability. J Phys Chem B 114, 7489, 2010.
136. Lu, H., et al. Culture of bovine articular chondrocytes in funnel-like collagen-PLGA hybrid sponges. Biomed Mater 6, 045011, 2011.
137. Wu, C., Fan, W., Zhu, Y., Gelinsky, M., Chang, J., Cuniberti, G., et al. Magnetic mesoporous bioactive glass scaffolds with hierarchical pore structure and multifunction. Acta Biomater 7, 3563, 2011.
138. Fu, Q., Saiz, E., and Tomsia, A.P. Direct ink writing of highly porous and strong glass scaffolds for load-bearing bone defects repair and regeneration. Acta Biomater 7, 3547, 2011.
139. Kennedy, J.P., McCandless, S.P., Rauf, A., Williams, L.M., Hillam, J., and Hitchcock, R.W. Engineered channels enhance cellular density in perfused scaffolds. Acta Biomater 7, 3896, 2011.
140. Jonitz, A., Lochner, K., Lindner, T., Hansmann, D., Marrot, A., and Bader, R. Oxygen consumption, acidification and migration capacity of human primary osteoblasts within a three-dimensional tantalum scaffold. J Mater Sci Mater Med 22, 2089, 2011.
141. Psycharakis, S., et al. Tailor-made three-dimensional hybrid scaffolds for cell cultures. Biomed Mater 6, 045008, 2011.
142. Boden, S.D., Kang, J., Sandhu, H., and Heller, J.G. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976) 27, 2662, 2002.
143. Luque, E. Latest Clinical Results Using Demineralized Bone Materials and rhBMP-2, the Mexican Experience. Total Spine: Advanced Concepts and Constructs. Cancun, Mexico: 2002.
144. Dawson, E., Bae, H.W., Burkus, J.K., Stambough, J.L., and Glassman, S.D. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am 91, 1604, 2009.
145. Szpalski, M., and Gunzburg, R. Recombinant human bone morphogenetic protein-2, a novel osteoinductive alternative to autogenous bone graft? Acta Orthop Belg 71, 133, 2005
146. Delloye, C., Suratwala, S.J.,Cornu, O., andLee, F.Y.Treatment of allograft nonunions with recombinant human bone morphogenetic proteins (rhBMP). Acta Orthop Belg 70, 591, 2004.
147. Epstein, NE., Pros, cons, and costs of INFUSE in spinal surgery. Surg Neurol Int 2, 10. 2011.
148. Deutsch, H. High-dose bone morphogenetic protein-induced ectopic abdomen bone growth. Spine J 10, 1, 2010.
149. Yaremchuk, K., Toma, M., and Somers, M. Acute airway obstruction associated with the use of bone-morphogenetic protein in cervical spinal fusion. Laryngoscope 120 Suppl 4, S140, 2010.
150. Lewandrowski, K.U., Nanson, C., and Calderon, R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2, a report of five cases. Spine J 7, 609, 2007.
151. Dickinson, B.P., Ashley, R.K., Wasson, K.L., O'Hara, C., Gabbay, J., Heller, J.B., et al. Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg 121, 209, 2008.
152. Fallucco, M.A., and Carstens, M.H. Primary reconstruction of alveolar clefts using recombinant human bone morphogenic protein-2, clinical and radiographic outcomes. J Craniofac Surg 20 Suppl 2, 1759, 2009.
153. Jung, R.E., Windisch, S.I., Eggenschwiler, A.M., Thoma, D.S., Weber, F.E., and Hammerle, C.H. A randomizedcontrolled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2. Clin Oral Implants Res 20, 660, 2009.